ID: ALA131104

Max Phase: Preclinical

Molecular Formula: C21H13NO5

Molecular Weight: 359.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1cc2cc(O)c(O)cc2c(C(=O)c2ccc3ccccc3c2)n1

Standard InChI:  InChI=1S/C21H13NO5/c23-17-9-14-8-16(21(26)27)22-19(15(14)10-18(17)24)20(25)13-6-5-11-3-1-2-4-12(11)7-13/h1-10,23-24H,(H,26,27)

Standard InChI Key:  XIFAVPVMZDXWME-UHFFFAOYSA-N

Associated Targets(Human)

Insulin-like growth factor binding protein 3 46 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 359.34Molecular Weight (Monoisotopic): 359.0794AlogP: 3.73#Rotatable Bonds: 3
Polar Surface Area: 107.72Molecular Species: ACIDHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.11CX Basic pKa: 6.62CX LogP: 1.94CX LogD: 1.10
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.38Np Likeness Score: 0.26

References

1. Chen C, Zhu YF, Liu XJ, Lu ZX, Xie Q, Ling N..  (2001)  Discovery of a series of nonpeptide small molecules that inhibit the binding of insulin-like growth factor (IGF) to IGF-binding proteins.,  44  (23): [PMID:11689087] [10.1021/jm010304b]

Source